Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1229.80
-15.95 (-1.28%) Dr. Reddy’s Laboratories informs about press release
Date: 29-07-2024Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy’s receives positive CHMP opinion from European Medicines Agency for its proposed Rituximab biosimilar’.
The above information is a part of company’s filings submitted to BSE.